End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
30,400 KRW | +2.01% | +4.29% | -14.49% |
03-14 | JW Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
01-22 | CJ Logistics Secures Distribution Deal for JW Pharm's Intravenous Solutions | MT |
Sales 2024 * | 827B 602M 822M | Sales 2025 * | 890B 647M 884M | Capitalization | 709B 515M 704M |
---|---|---|---|---|---|
Net income 2024 * | 73B 53.07M 72.49M | Net income 2025 * | 72B 52.34M 71.5M | EV / Sales 2024 * | 0.98 x |
Net Debt 2024 * | 104B 75.39M 103M | Net Debt 2025 * | 88.55B 64.38M 87.93M | EV / Sales 2025 * | 0.9 x |
P/E ratio 2024 * |
9.95
x | P/E ratio 2025 * |
10.1
x | Employees | 1,197 |
Yield 2024 * |
1.19% | Yield 2025 * |
1.19% | Free-Float | 52.98% |
1 day | +2.01% | ||
1 week | +4.29% | ||
Current month | -6.75% | ||
1 month | -8.43% | ||
3 months | -10.72% | ||
6 months | +17.90% | ||
Current year | -14.49% |
Managers | Title | Age | Since |
---|---|---|---|
Seong-Yeol Lee
CEO | Chief Executive Officer | 61 | - |
Yeong-Seob Shin
CEO | Chief Executive Officer | 61 | - |
Kyung-Ha Lee
CHM | Chairman | 60 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Kyung-Ha Lee
CHM | Chairman | 60 | - |
Seong-Yeol Lee
CEO | Chief Executive Officer | 61 | - |
Gyu-Eon Jung
BRD | Director/Board Member | 62 | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 4 M€ | -4.41% | - | |
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 30,400 | +2.01% | 34,283 |
24-04-25 | 29,800 | -2.30% | 46,451 |
24-04-24 | 30,500 | +2.87% | 84,890 |
24-04-23 | 29,650 | 0.00% | 45,311 |
24-04-22 | 29,650 | +1.72% | 35,673 |
End-of-day quote Korea S.E., April 25, 2024
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.49% | 515M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- A001060 Stock